Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with metastatic renal cell carcinoma (mRCC).
Daniel C. Cho
No relevant relationships to disclose
Jeffrey Alan Sosman
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Mario Sznol
Consultant or Advisory Role - Bristol-Myers Squibb; Genesis Pharmaceuticals
Michael S. Gordon
Consultant or Advisory Role - Genentech
Research Funding - Genentech/Roche
Antoine Hollebecque
No relevant relationships to disclose
Omid Hamid
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
David F. McDermott
Consultant or Advisory Role - Genentech/Roche
Jean-Pierre Delord
No relevant relationships to disclose
Ina Park Rhee
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Roche
Ahmad Mokatrin
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Marcin Kowanetz
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Roel Peter Funke
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Gregg Daniel Fine
Employment or Leadership Position - Genentech
Stock Ownership - Genentech/Roche
Thomas Powles
No relevant relationships to disclose